Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.33
+0.13 (0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
21.26
-0.07 (-0.33%)
After-hours: Mar 9, 2026, 7:53 PM EDT
DAWN Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -107.32 | -95.5 | -188.92 | -142.18 | -70.65 | |
| Depreciation & Amortization | 3.79 | 2.03 | 0.38 | 0.53 | 0.2 | |
| Loss (Gain) From Sale of Assets | 0.07 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | - | 55 | 3 | - | 8 | |
| Loss (Gain) From Sale of Investments | -15.74 | -6.39 | -10.08 | -2.03 | - | |
| Stock-Based Compensation | 44.39 | 48.26 | 39.34 | 27.24 | 13.32 | |
| Other Operating Activities | - | -108 | - | - | -2.11 | |
| Change in Accounts Receivable | -12.86 | -13.88 | - | - | - | |
| Change in Inventory | -2.86 | -3.24 | - | - | - | |
| Change in Accounts Payable | 0.47 | 0.69 | 2.32 | -1.48 | 1.54 | |
| Change in Unearned Revenue | 0.25 | 4.79 | - | - | - | |
| Change in Other Net Operating Assets | -13.95 | 38.13 | 7.1 | 8.05 | 1.15 | |
| Operating Cash Flow | -103.76 | -78.11 | -146.85 | -109.87 | -48.54 | |
| Capital Expenditures | -0.32 | -2.17 | -0.22 | -0.03 | - | |
| Sale of Property, Plant & Equipment | 0.03 | - | - | - | - | |
| Sale (Purchase) of Intangibles | -3.5 | -72.1 | -3 | - | -8 | |
| Investment in Securities | 178.44 | -264.73 | 131.6 | -255.05 | - | |
| Other Investing Activities | - | 108 | - | - | - | |
| Investing Cash Flow | 174.65 | -230.99 | 128.38 | -255.07 | -8 | |
| Issuance of Common Stock | 1.22 | 182.35 | 164 | 165.9 | 167.36 | |
| Other Financing Activities | - | 20.94 | - | - | - | |
| Financing Cash Flow | 1.22 | 203.29 | 164 | 165.9 | 297.12 | |
| Net Cash Flow | 72.11 | -105.82 | 145.52 | -199.05 | 240.58 | |
| Free Cash Flow | -104.08 | -80.28 | -147.08 | -109.9 | -48.54 | |
| Free Cash Flow Margin | -65.80% | -61.21% | - | - | - | |
| Free Cash Flow Per Share | -1.01 | -0.86 | -1.84 | -1.68 | -1.31 | |
| Cash Income Tax Paid | 4.75 | 1.9 | - | - | - | |
| Levered Free Cash Flow | -61.96 | -133.99 | -82.72 | -56.86 | -37.01 | |
| Unlevered Free Cash Flow | -61.96 | -133.99 | -82.72 | -56.86 | -37.01 | |
| Change in Working Capital | -28.94 | 26.48 | 9.42 | 6.56 | 2.7 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.